We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

340B Program: HRSA Releases Proposed Rule on Calculation of the Ceiling Price and Imposition of Civil Monetary Penalties on Manufacturers

16 June 2015

Health, Pharmaceutical, and Biotechnology Alert

Today, the Health Resources and Services Administration (HRSA) released a Notice of Proposed Rulemaking (NPRM) regarding the calculation of the 340B ceiling price and the imposition of civil monetary penalties (CMPs) on manufacturers that knowing and intentionally overcharge 340B covered entities.

Read more: 340B Program: HRSA Releases Proposed Rule on Calculation of the Ceiling Price and Imposition of Civil Monetary Penalties on Manufacturers

The team

Loading data